ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2152

Frequency of Postoperative Deep Infection in Patients with Rheumatoid Arthritis

Masayuki Azukizawa and Hiromu Ito, Orthopaedic surgery, Kyoto University, Kyoto, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Biologic agents, Infection, orthopaedic, rheumatoid arthritis (RA) and surgery

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Infections, Infection-related Biomarkers and Impact of Biologic Therapies

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is known to be associated with an increased risk of serious infection. It has been discussed about the risk of the surgical site infection in the RA patients. However there are few reports about the postoperative deep infection in those patients. The aims of the study were to investigate the postoperative deep infection in RA patients treated in our institution and to clarify the frequency of the postoperative deep infection.

Methods: We reviewed a total of 696 orthopaedic surgeries for RA patients underwent between January 2004 and December 2013. We investigated the cases of deep infection after surgery, the sites of infection, and surgical techniques. We researched the postoperative deep infection free rate for the RA patients.

Results: The mean follow-up period was 4.7 years. 27.3% of all RA patients used Biological DMARDs. Twenty-five cases (3.6%) were suffered from the postoperative deep infection. Infection sites (surgical procedures) are 5 hips (bipolar hemiarthroplasty and total hip arthroplasty), 6 knees (total knee arthroplasty), 6 elbows (total elbow arthroplasty), one shoulder (total shoulder arthroplasty), 2 hands (metacarpophalangeal joint arthroplasty and proximal interpharangeal joint arthroplasty), one ankle (ankle arthrodesis) and 4 spines (Magerl technique, cervical posterior fixation, transforaminal lumbar interbody fusion). According to the Kaplan-Meier survival analysis, the cumulative deep infection free rate of all patients in 3 months, in 2 years and in 5 years was 98.7%, 97.8%, and 97.0%, respectively. That of the patient treated with biologic DMARDs was significantly lower than that of without biologic DMARDs. (Log-rank Test: p = 0.0068)

Conclusion: These results suggest that the postoperative deep infection is likely to occur within the first 3 months after surgery in the RA patients, and that the use of biological DMARDs is a risk factor for postoperative deep infection. We should pay more attention to the postoperative deep infection within 3 months of a procedure.

�à–¾: Macintosh HD:Users:masayuki:Desktop:ACRfigure:figure1.jpg

�à–¾: Macintosh HD:Users:masayuki:Desktop:ACRfigure:figure2.jpg


Disclosure:

M. Azukizawa,
None;

H. Ito,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frequency-of-postoperative-deep-infection-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology